Literature DB >> 32395173

In Vivo Corneal Confocal Microscopy: Pre- and Post-operative Evaluation in a Case of Corneal Neurotization.

Roberto Ebner1, Guillermo Fridrich1, Mariano Socolovsky2, Analía Luna3, Juan Oscar Croxatto4.   

Abstract

In this report, we analyse the pre- and post-operative corneal changes observed using in vivo confocal corneal microscopy in a patient with neurotrophic keratitis submitted to a corneal reinnervation surgical procedure. We describe favourable trophic changes observed at different levels of the patient's cornea, particularly in the sub-basal nerve plexus; complete absence of these neurological structures was observed before surgery, but appeared largely restored six months thereafter.
© 2019 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Corneal confocal microscopy; corneal neurotization; neurotrophic keratitis

Year:  2019        PMID: 32395173      PMCID: PMC7202412          DOI: 10.1080/01658107.2019.1568508

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  4 in total

1.  In vivo confocal microscopic evaluation of Langerhans cell density and distribution in the normal human corneal epithelium.

Authors:  Andrey Zhivov; Joachim Stave; Brigitte Vollmar; Rudolf Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

2.  Face lifting in the massive weight loss patient: modifications of our technique for this population.

Authors:  Kailash Narasimhan; Smita Ramanadham; Rod J Rohrich
Journal:  Plast Reconstr Surg       Date:  2015-02       Impact factor: 4.730

3.  Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells.

Authors:  Pedram Hamrah; Qiang Zhang; Ying Liu; M Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-03       Impact factor: 4.799

4.  Corneal neurotization: a novel solution to neurotrophic keratopathy.

Authors:  Julia K Terzis; Marylou M Dryer; Bruce I Bodner
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.